{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:05:12Z","timestamp":1791119112386,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":4504,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1046\/j.1469-0691.2002.00500.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T07:28:00Z","timestamp":1047367680000},"page":"479-488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Anthrax in Europe: its epidemiology, clinical characteristics, and role in bioterrorism"],"prefix":"10.1016","volume":"8","author":[{"given":"G.","family":"Schmid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kaufmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1046\/j.1469-0691.2002.00500.x_bib1","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3201\/eid0504.990418","article-title":"Clinical and epidemiologic principles of anthrax","volume":"5","author":"Cieslak","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib2","series-title":"Interim PHLS guidelines for action in the event of a deliberate release","year":"2001"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib3","first-page":"909","article-title":"Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001","volume":"50","year":"2001","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib4","first-page":"987","article-title":"Interim guidelines for investigation of and response to Bacillus anthracis exposures","volume":"50","year":"2001","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib5","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1001\/jama.281.18.1735","article-title":"Anthrax as a biological weapon: medical and public health management","volume":"281","author":"Inglesby","year":"1999","journal-title":"JAMA"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib6","year":"2002","journal-title":"Medscape"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3201\/eid0706.010604","article-title":"Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States","volume":"7","author":"Jernigan","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib8","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3201\/eid0403.980340","article-title":"Bioterrorism as a public health threat","volume":"4","author":"Henderson","year":"1998","journal-title":"Emerg Infect Dis"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3201\/eid0302.970201","article-title":"The economic impact of a bioterrorist attack: are prevention and postattack intervention programs justifiable?","volume":"3","author":"Kaufmann","year":"1997","journal-title":"Emerg Infect Dis"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1749-6632.1980.tb18910.x","article-title":"Inhalation anthrax","volume":"353","author":"Brachman","year":"1980","journal-title":"Ann NY Acad Sci"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib11","series-title":"Guidelines for the surveillance and control of anthrax in humans and animals","first-page":"1","author":"Turnbull","year":"1998"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1046\/j.1365-2672.1999.00867.x","article-title":"1996-1997 Global anthrax report","volume":"87","author":"Hugh-Jones","year":"1999","journal-title":"J Appl Microbiol"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib13","first-page":"9S","article-title":"The monitoring and detection of Bacillus anthracis in the environment","volume":"70","author":"Titball","year":"1991","journal-title":"J Appl Bacteriol Symp Suppl"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib14","article-title":"Anthrax in Australia","author":"Geering","year":"1997","journal-title":"Inter-regional workshop on anthrax"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib15","series-title":"Infectious diseases and their etiologic agents","first-page":"1885","article-title":"Bacillus anthracis (anthrax)","author":"Lew","year":"2000"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib16","unstructured":"Alper T. Development of the \u2018Sterne strain\u2019 of anthrax. In: International workshop on anthrax 1995, Winchester."},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib17","series-title":"World Health Organization Collaborating Center for remote sensing and geographic information systems for public health","author":"Hugh-Jones","year":"2002"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib18","unstructured":"Cherkasskiy B. Russian experience in immunisation against anthrax. In: Inter-Regional Workshop on Anthrax 1997, Kathmandu."},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib19","first-page":"1094","article-title":"A European centre to respond to threats of bioterrorism and major epidemics","volume":"79","author":"Tibayrenc","year":"2001","journal-title":"Bull WHO Org"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1136\/bmj.323.7317.818","article-title":"Surveillance for infectious diseases in the European Union","volume":"323","author":"Peterson","year":"2001","journal-title":"BMJ"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib21","first-page":"477","article-title":"Visceral form of human anthrax imported from Africa","volume":"23","author":"Paulet","year":"1994","journal-title":"Presse Med"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib22","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/S0140-6736(00)03133-0","article-title":"Injectional anthrax in a heroin skin-popper","volume":"356","author":"Ringertz","year":"2000","journal-title":"Lancet"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00000372-199702000-00014","article-title":"Extraordinary case report: cutaneous anthrax","volume":"19","author":"Mallon","year":"1997","journal-title":"Am J Dermatopathol"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib24","first-page":"813","article-title":"Eine Milzbrandepidemie in der Schweiz","volume":"121","author":"Pfisterer","year":"1991","journal-title":"Schweiz Med Wschr"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib25","first-page":"160","article-title":"Anthrax in humans in Zimbabwe","volume":"26","author":"Turner","year":"1980","journal-title":"Cent Afr J Med"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib26","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1017\/S0022172400063488","article-title":"Anthrax. William Smith Greenfield, M.D., F.R.C.P., Professor Superintendent, The Brown Animal Sanatory Institution (1878-81)","volume":"85","author":"Tigertt","year":"1980","journal-title":"J Hyg Camb"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib27","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1126\/science.7973702","article-title":"The Sverdlovsk anthrax outbreak of 1979","volume":"266","author":"Meselson","year":"1994","journal-title":"Science"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib28","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.1997.03550050074036","article-title":"Biological warfare: a historical perspective","volume":"278","author":"Christopher","year":"1997","journal-title":"JAMA"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib29","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1128\/JCM.39.12.4566-4567.2001","article-title":"Molecular investigation of the Aum Shinrikyo anthrax release in Kameido, Japan","volume":"39","author":"Keim","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib30","article-title":"The Kameido incident: documentation of a failed bioterrorist attack","author":"Takahashi","year":"2001","journal-title":"4th International conference on anthrax"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib31","series-title":"Proliferation of weapons of mass destruction","first-page":"53","year":"1993"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib32","series-title":"Health aspects of chemical and biological weapons","first-page":"98","year":"1970"},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib33","unstructured":"Turnbull PCB. Bits and pieces (from the poster boards at the workshop). In: Proceedings of the international workshop on anthrax 1995, Winchester."},{"key":"10.1046\/j.1469-0691.2002.00500.x_bib34","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1128\/br.30.3.657-659.1966","article-title":"Discussion","volume":"30","author":"Glassman","year":"1966","journal-title":"Bacteriol Rev"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14626379?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14626379?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:16:01Z","timestamp":1761117361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14626379"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":34,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["S1198743X14626379"],"URL":"https:\/\/doi.org\/10.1046\/j.1469-0691.2002.00500.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2002,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anthrax in Europe: its epidemiology, clinical characteristics, and role in bioterrorism","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1046\/j.1469-0691.2002.00500.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2002 European Society of Clinical Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}